Award
National Institute of Allergy and Infectious Diseases 5R44AI109891-08
Point-of-care lateral flow immunoassay for diagnosis of pertussis
Recipient
Not Specified
Award Amount
$989,461.00
Ceiling
$989,461.00
Awarded
April 24, 2025
Identifier
5R44AI109891-08
Award for developing a rapid diagnostic test for pertussis using lateral flow immunoassay technology, funded by NIAID as part of a Phase IIb project.
Description
The project aims to develop a rapid, point-of-care, lateral flow immunoassay to detect Bordetella pertussis. The award is part of a Phase IIb effort to deliver an FDA-cleared diagnostic. The project builds on previous phases, including identification of a specific biomarker (TcfA) and development of monoclonal antibodies. The project involves pre-clinical and clinical evaluation phases. The funding is provided by the National Institute of Allergy and Infectious Diseases (NIAID), NIH.